{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:23:25Z","timestamp":1794565405316,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.diabres.2026.113297","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:24:10Z","timestamp":1777929850000},"page":"113297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipidomics analysis to assess metabolic complications in familial partial lipodystrophy type 2"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5752-138X","authenticated-orcid":false,"given":"Julie","family":"Koue-Chon-Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtamu B.","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6050-1259","authenticated-orcid":false,"given":"Corey","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Treiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Mellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Cinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Couret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Cogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Meilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Simonson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Veeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Nob\u00e9court","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113297_b0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-21-0282","article-title":"A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies","volume":"185","author":"Treiber","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2026.113297_b0010","doi-asserted-by":"crossref","first-page":"E856","DOI":"10.1210\/jc.2010-2234","article-title":"A homozygous mutation of prelamin-a preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-a","volume":"96","author":"Le Dour","year":"2011","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2026.113297_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101409","article-title":"Lipoatrophic diabetes in familial partial lipodystrophy type 2: from insulin resistance to diabetes","volume":"49","author":"Treiber","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2026.113297_b0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurjpc\/zwae279","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","volume":"32","author":"Koskinas","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.diabres.2026.113297_b0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/oby.23049","article-title":"The metabolic equivalent BMI in patients with Familial Partial Lipodystrophy (FPLD) compared with those with severe obesity","volume":"29","author":"Koo","year":"2021","journal-title":"Obesity"},{"key":"10.1016\/j.diabres.2026.113297_b0030","doi-asserted-by":"crossref","first-page":"e1041","DOI":"10.1210\/clinem\/dgaa054","article-title":"Mapping the associations of the plasma lipidome with insulin resistance and response to an oral glucose tolerance test","volume":"105","author":"Beyene","year":"2020","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2026.113297_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2017.08.014","article-title":"Lipidome as a predictive tool in progression to type 2 diabetes in finnish men","volume":"78","author":"Suvitaival","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2026.113297_b0040","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.116.023233","article-title":"Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus","volume":"134","author":"Alshehry","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113297_b0045","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1038\/s41467-023-41963-7","article-title":"Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts","volume":"14","author":"Beyene","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.diabres.2026.113297_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-20-1013","article-title":"LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells","volume":"184","author":"Sollier","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2026.113297_b0055","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2214\/AJR.07.4016","article-title":"Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis","volume":"192","author":"Webb","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.diabres.2026.113297_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.chembiol.2018.10.008","article-title":"High-throughput plasma lipidomics: detailed mapping of the associations with cardiometabolic risk factors","volume":"26","author":"Huynh","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.diabres.2026.113297_b0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/metabo5020389","article-title":"An efficient single phase method for the extraction of plasma lipids","volume":"5","author":"Alshehry","year":"2015","journal-title":"Metabolites"},{"key":"10.1016\/j.diabres.2026.113297_b0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"10.1016\/j.diabres.2026.113297_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074341","article-title":"Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes","volume":"8","author":"Meikle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2026.113297_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.803189","article-title":"Molecular and Cellular Bases of Lipodystrophy Syndromes","volume":"12","author":"Zammouri","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2026.113297_b0085","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacl.2021.07.004","article-title":"Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2","volume":"15","author":"Lazarte","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.diabres.2026.113297_b0090","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2337\/diacare.26.5.1350","article-title":"Risk factors for diabetes in familial partial lipodystrophy","volume":"26","author":"Haque","year":"2003","journal-title":"Dunnigan Variety Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113297_b0095","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.diabet.2019.12.006","article-title":"Is the type 2 diabetes epidemic plateauing in France? a nationwide population-based study","volume":"46","author":"Fuentes","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2026.113297_b0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/21623945.2020.1776082","article-title":"The common pathophysiologic threads between Asian Indian diabetic\u2019s \u2018Thin Fat Phenotype\u2019 and partial lipodystrophy: the peripheral adipose tissue transcriptomic evidences","volume":"9","author":"Saxena","year":"2020","journal-title":"Adipocyte"},{"key":"10.1016\/j.diabres.2026.113297_b0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/biom8030047","article-title":"Genetics of lipodystrophy: can it help in understanding the pathophysiology of metabolic syndrome?","volume":"8","author":"Mathur","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.diabres.2026.113297_b0110","doi-asserted-by":"crossref","unstructured":"Varlamov O, Bethea CL, Roberts CT. Sex-specific differences in lipid and glucose metabolism. Front Endocrinol; 5. Epub ahead of print 19 January 2015. doi: 10.3389\/fendo.2014.00241.","DOI":"10.3389\/fendo.2014.00241"},{"key":"10.1016\/j.diabres.2026.113297_b0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2042-6410-3-13","article-title":"Sex differences in human adipose tissues \u2013 the biology of pear shape","volume":"3","author":"Karastergiou","year":"2012","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.diabres.2026.113297_b0120","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1194\/jlr.M081398","article-title":"Genetic, dietary, and sex-specific regulation of hepatic ceramides and the relationship between hepatic ceramides and IR","volume":"59","author":"Norheim","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabres.2026.113297_b0125","article-title":"High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: evidence from two large population cohort studies","volume":"18","author":"Beyene","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.diabres.2026.113297_b0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.molmet.2018.04.003","article-title":"Sex differences in obesity, lipid metabolism, and inflammation\u2014a role for the sex chromosomes?","volume":"15","author":"Zore","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.diabres.2026.113297_b0135","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00032.2020","article-title":"Lipodystrophy: a paradigm for understanding the consequences of \u2018overloading\u2019 adipose tissue","author":"Lim","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.diabres.2026.113297_b0140","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2015-3525","article-title":"Lipidomics reveals associations of phospholipids with obesity and insulin resistance in young adults","volume":"101","author":"Rauschert","year":"2016","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.diabres.2026.113297_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041456","article-title":"Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes","volume":"7","author":"Barber","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2026.113297_b0150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/ajcn\/nqaa195","article-title":"Distinct infrastructure of lipid networks in visceral and subcutaneous adipose tissues in overweight humans","volume":"112","author":"Zacharia","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabres.2026.113297_b0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13293-018-0189-3","article-title":"Sex differences in body composition and association with cardiometabolic risk","volume":"9","author":"Schorr","year":"2018","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.diabres.2026.113297_b0160","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1172\/JCI129190","article-title":"What lipodystrophies teach us about the metabolic syndrome","volume":"129","author":"Mann","year":"2019","journal-title":"J Clin Investig"},{"key":"10.1016\/j.diabres.2026.113297_b0165","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jn\/135.4.681","article-title":"Sexual dimorphism in human lipid metabolism","volume":"135","author":"Mittendorfer","year":"2005","journal-title":"J Nutr"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:25:43Z","timestamp":1794561943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"alternative-id":["S0168822726002172"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113297","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipidomics analysis to assess metabolic complications in familial partial lipodystrophy type 2","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113297"}}